Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DNA topoisomerase 1 (Homo sapiens (Human)) | BDBM50073854 (2,10-dihydroxy-12-(3,4,5-trihydroxy-6-hydroxymethy...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid PDB UniChem Similars | PDB Article PubMed | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
deCODE BioStructures Curated by ChEMBL | Assay Description Inhibition of topoisomerase I-DNA complex in trapping assay | J Med Chem 48: 2336-45 (2005) Article DOI: 10.1021/jm049146p BindingDB Entry DOI: 10.7270/Q2CF9QVT | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
DNA topoisomerase 1 (Homo sapiens (Human)) | BDBM50008935 ((20S)-10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase CHEMBL DrugBank MCE KEGG MMDB PC cid PC sid PDB UniChem Patents Similars | PDB Article PubMed | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
deCODE BioStructures Curated by ChEMBL | Assay Description Inhibition of topoisomerase I-DNA complex in trapping assay | J Med Chem 48: 2336-45 (2005) Article DOI: 10.1021/jm049146p BindingDB Entry DOI: 10.7270/Q2CF9QVT | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486277 (US10947210, Compound 14-7A) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486076 (US10947210, Compound 06-7F) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486194 (US10947210, Compound 11-6A) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486200 (US10947210, Compound 11-6B) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486221 (US10947210, Compound 12-7A) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486222 (US10947210, Compound 12-7B) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486330 (US10947210, Compound 28-8B) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486303 (US10947210, Compound 18-10B) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486304 (US10947210, Compound 19-8A) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486305 (US10947210, Compound 19-8B) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486307 (US10947210, Compound 20-8) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486308 (US10947210, Compound 21-5) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486321 (US10947210, Compound 26-7A) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486329 (US10947210, Compound 28-8A) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
DNA topoisomerase 1 (Homo sapiens (Human)) | BDBM50008923 ((S)-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase CHEMBL DrugBank MCE KEGG PC cid PC sid PDB UniChem Patents Similars | PDB Article PubMed | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
deCODE BioStructures Curated by ChEMBL | Assay Description Inhibition of topoisomerase I-DNA complex in trapping assay | J Med Chem 48: 2336-45 (2005) Article DOI: 10.1021/jm049146p BindingDB Entry DOI: 10.7270/Q2CF9QVT | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM485959 (US10947210, Compound 02-10A) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM485967 (US10947210, Compound 02-10C) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486035 (US10947210, Compound 03-8A) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486054 (US10947210, Compound 06-6A | US10947210, Compound ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486060 (US10947210, Compound 06-6D) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486062 (US10947210, Compound 06-6E) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486054 (US10947210, Compound 06-6A | US10947210, Compound ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486067 (US10947210, Compound 06-7B) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486068 (US10947210, Compound 06-7C) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486072 (US10947210, Compound 06-7D) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486075 (US10947210, Compound 06-7E | US10947210, Compound ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486088 (US10947210, Compound 06-8B3) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486089 (US10947210, Compound 06-8B4) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486090 (US10947210, Compound 06-8B5) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486091 (US10947210, Compound 06-8B6) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486096 (US10947210, Compound 06-8B7) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486098 (US10947210, Compound 06-8B8) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486102 (US10947210, Compound 08-6) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486103 (US10947210, Compound 09-14A) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486191 (US10947210, Compound 11-5A) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486214 (US10947210, Compound 11-6C) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486220 (US10947210, Compound 12-6A) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486223 (US10947210, Compound 12-7C) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486224 (US10947210, Compound 13-7A) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486225 (US10947210, Compound 13-7B) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486231 (US10947210, Compound 13-7C) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486233 (US10947210, Compound 13-7D) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486235 (US10947210, Compound 13-8A) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486238 (US10947210, Compound 13-8B) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486239 (US10947210, Compound 13-8C) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486241 (US10947210, Compound 13-8D) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486246 (US10947210, Compound 14-6A) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus genotype 3a (isolate k3a) (HCV)) | BDBM486282 (US10947210, Compound 14-7B) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
COCRYSTAL PHARMA, INC. US Patent | Assay Description The reaction mixtures consisted of 50 mM Hepes-KOH, pH 7.5, 5 mM MgCl2, 5 mM DTT, 2% glycerol, 0.01% Triton® X-100, 0.5 uM polyA:U16 substrate, purif... | US Patent US10947210 (2021) BindingDB Entry DOI: 10.7270/Q2CZ3B8J | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 168 total ) | Next | Last >> |